Do the sites of metastases provide additional information regarding prognosis and biology in renal cell carcinoma?

Eur Urol. 2014 Mar;65(3):585-6. doi: 10.1016/j.eururo.2013.09.001. Epub 2013 Sep 9.

Authors

Guru Sonpavde¹, Sunil Sudarshan², Bernard Escudier³

Affiliations

¹ Department of Medicine, Section of Hematology-Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA. Electronic address: gsonpavde@uabmc.edu.
² Department of Urology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL, USA.
³ Institut Gustave Roussy, Villejuif, France.

PMID: 24044979
DOI: 10.1016/j.eururo.2013.09.001

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Bone Neoplasms / secondary*
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / secondary*
Female
Humans
Kidney Neoplasms / drug therapy*
Kidney Neoplasms / pathology*
Liver Neoplasms / secondary*
Male